A researcher is developing a patent-pending platform technology called LENN that mimics the dual-layer structure of viruses to deliver nucleic acid (NA)-based therapies to targeted cancer cells. A ...

This is a preview. Log in through your library . Abstract Type I interferons (IFNs) are innate immune cytokines required to establish cellular host defense. Precise control of IFN gene expression is ...

How does UV-Vis spectrophotometry help with the understanding of failed reactions? Genomic analyses, such as next-generation sequencing (NGS) and quantitative polymerase chain reaction (qPCR), require ...

WEST LAFAYETTE, Ind. — A researcher in Purdue University’s College of Science is developing a patent-pending platform technology that mimics the dual-layer structure of viruses to deliver nucleic acid ...

Purdue University researcher David Thompson has developed LENN, a system to deliver nucleic acid-based therapies to targeted cancer cells. His and his team’s research into using LENN to deliver ...